AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to ...

The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...

We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.

Stocks opened higher on Wednesday ahead of the Federal Reserve’s interest rate announcement at 2 p.m., which will be followed ...

In work conducted by Jining Medical University investigators, synthesis and optimization of a previously reported ...

The 28th annual Better Workplace Conference will address emerging workplace challenges, such as polarization and technology-induced burnout, and explore how to meet the diverse needs and requirements ...

Biopharma deal activity climbed in early 2025, reaching $37.38 billion in the first two months, up from $35.66 billion a year ago. February saw $8.76 billion in deals, down 69% from January’s $28.63 ...

The 2024/25 UEFA Conference League final will take place at Stadion Wrocław in Wroclaw, Poland on Wednesday 28 May. The 2024/25 UEFA Conference League season will conclude at Stadion Wrocław in ...

In the 2024 NCAA men's championship, UConn beat Purdue to take home their sixth title and bring glory to the Big East conference. Which conference has won the most national championships in men's ...

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...